Pakistan tops global hepatitis C burden as banned syringes fuel crisis: WHO 2026
Synopsis
Key Takeaways
Pakistan has been identified as the world's single largest contributor to the global hepatitis C burden, according to the WHO Global Hepatitis Report 2026, even as field investigations from across the country continue to document the open availability of banned reusable syringes and counterfeit auto-disable syringes in local markets. Health experts warn that repeated use of such equipment by unqualified practitioners is actively fuelling transmission of hepatitis B, hepatitis C, and HIV.
Pakistan's Place in the Global Hepatitis Crisis
Pakistan is among the 10 nations that together accounted for 58 per cent of the world's hepatitis C-linked deaths in 2024. The WHO report notes that global progress on eliminating hepatitis remains dangerously slow, with 1.34 million people losing their lives to hepatitis B and C combined in a single year. The report attributes the global burden to historical transmission, unsafe medical practices, and injecting drug use — a combination that, critics argue, describes Pakistan's healthcare landscape with troubling precision.
An editorial in Pakistani daily The News International stated: